Tenet Healthcare (NYSE:THC) EVP Sells 24,000 Shares of Stock

Tenet Healthcare Corporation (NYSE:THC) EVP Lisa Foo sold 24,000 shares of the company’s stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $266.32, for a total value of $6,391,680.00. Following the sale, the executive vice president directly owned 8,053 shares in the company, valued at $2,144,674.96. This trade represents a 74.88% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Tenet Healthcare Price Performance

Tenet Healthcare stock traded down $0.56 during mid-day trading on Tuesday, reaching $265.35. 815,961 shares of the company’s stock traded hands, compared to its average volume of 758,688. The stock has a 50 day moving average of $233.42 and a two-hundred day moving average of $210.44. Tenet Healthcare Corporation has a 12-month low of $157.58 and a 12-month high of $283.05. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00. The company has a market cap of $21.37 billion, a price-to-earnings ratio of 10.23, a PEG ratio of 1.02 and a beta of 1.23.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. The firm had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the firm earned $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Equities analysts forecast that Tenet Healthcare Corporation will post 20.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

THC has been the topic of a number of recent analyst reports. Barclays increased their price objective on shares of Tenet Healthcare from $240.00 to $271.00 and gave the stock an “overweight” rating in a research report on Friday, July 24th. Morgan Stanley upped their target price on Tenet Healthcare from $254.00 to $274.00 and gave the company an “overweight” rating in a research note on Monday, July 27th. Stephens reissued an “overweight” rating and set a $285.00 price target on shares of Tenet Healthcare in a research note on Monday, July 27th. Wall Street Zen upgraded Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Sunday, August 23rd. Finally, Robert W. Baird increased their target price on Tenet Healthcare from $210.00 to $280.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 28th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $273.00.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Triumph Capital Management purchased a new stake in shares of Tenet Healthcare in the 3rd quarter worth approximately $25,000. Elyxium Wealth LLC purchased a new position in shares of Tenet Healthcare in the 4th quarter valued at $29,000. Canada Pension Plan Investment Board bought a new position in shares of Tenet Healthcare in the 2nd quarter worth $35,000. Trust Co. of Vermont bought a new stake in Tenet Healthcare during the second quarter valued at about $37,000. Finally, Meeder Asset Management Inc. grew its stake in Tenet Healthcare by 146.2% in the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after purchasing an additional 114 shares during the last quarter. 95.44% of the stock is currently owned by institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.